Developer of human gene-based therapies. The company has developed a platform to bring new disease-modifying therapies to patients with severe disorders. The company's pipeline includes gene-based therapies for lipoprotein lipase deficiency, or LPLD, Sanfilippo B, Parkinson's Disease and Hemophilia B.read more
The environment at uniQure is considered positive by 100% of employees and regarded as having an “extremely fast” work pace by 2 employees. uniQure ranks in the Top 5% of 1590 similar sized companies (201-500 Employees) on Comparably.
Rate Environment the Highest
Not Enough Ratings To Show Who Ranks Environment the Highest